Drug Therapy
US Congress 114th Congress
Improving Regulatory Transparency for New Medical Therapies Act [S.481]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Law Enforcement ]
[Criminal Justice ]
[Crime ]
Improving Regulatory Transparency for New Medical Therapies Act (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to delay the effective date of approval of a drug, biological product, or animal drug for which the Food and Drug Administration (FDA) recommends controls under the Controlled Substances Act until the Department of Justice (DOJ) issues a final interim rule for the drug. This delay also applies to conditional approval and indexing of animal drugs. This bill amends the Controlled Substances
(continued...)
Spread the world
Gettr US Congress 114th Congress
RACE for Children Act Research to Accelerate Cures and Equity for Children Act [S.3239]
[Healthcare ]
[Public Health ]
[Children and Youth ]
[Science ]
RACE for Children Act Research to Accelerate Cures and Equity for Children Act
Spread the world
US Congress 114th Congress
STAAR Act Strategies to Address Antibiotic Resistance Act [S.3176]
[Healthcare ]
[Public Health ]
[Science ]
[Pharmaceuticals ]
STAAR Act Strategies to Address Antibiotic Resistance Act
Spread the world
US Congress 114th Congress
MEDS Act Marijuana Effective Drug Studies Act of 2016 [S.3077]
[Cannabis ]
[Healthcare ]
[Pharmaceuticals ]
[Science ]
MEDS Act Marijuana Effective Drug Studies Act of 2016
Spread the world
US Congress 114th Congress
Addiction Prevention and Responsible Opioid Practices Act [S.3075]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Mental Health ]
Addiction Prevention and Responsible Opioid Practices Act
Spread the world
US Congress 114th Congress
GAO Mandates Revision Act of 2016 [S.2964]
[Finance ]
[Healthcare ]
[Medicare and Medicaid ]
[Consumer Protection ]
[Public Health ]
[Funding ]
[Grants ]
GAO Mandates Revision Act of 2016 (Sec. 2) This bill eliminates provisions that require the Government Accountability Office (GAO) to: review reported legislation that requires financial audits of nonfederal entities receiving federal awards; evaluate the extent to which premium levels for Medicare supplemental policies reflect reductions in coinsurance for hospital outpatient services made by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000 under part B (Supplementary Medical Insurance Benefits for Aged and Disabled)
(continued...)
Spread the world
US Congress 114th Congress
Veterans First Act [S.2921]
[Veterans ]
Veterans First Act
Spread the world
US Congress 114th Congress
Trickett Wendler Right to Try Act of 2016 [S.2912]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
Trickett Wendler Right to Try Act of 2016 This bill bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, or dispensing of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. The federal government may not restrict the possession or use of such a treatment by a patient certified by a physician as having exhausted all other treatment options.
(continued...)
Spread the world
US Congress 114th Congress
Jessie's Law [S.2866]
Jessie's Law
Spread the world
US Congress 114th Congress
Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016 [S.2861]
[Healthcare ]
[Veterans ]
[Pharmaceuticals ]
[Mental Health ]
[Military ]
[Public Health ]
Post-Traumatic Stress Disorder Medication Prescribing Improvement Act of 2016 This bill directs the Department of Defense to: (1) review the prescribing practices at military treatment facilities of pharmaceutical agents for post-traumatic stress treatment, (2) implement a process or processes to monitor the prescribing practices at military treatment facilities of pharmaceutical agents that are discouraged from use under the VA/DOD Clinical Practice Guideline for Management of Post-Traumatic Stress, and (3) implement a plan to address deviations
(continued...)
Spread the world
US Congress 114th Congress
Prescription Drug and Health Improvement Act of 2016 [S.2858]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
Prescription Drug and Health Improvement Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate lower prices on behalf of Medicare and Medicare Advantage (MA) beneficiaries for covered prescription drugs that CMS deems appropriate for negotiation based on: (1) program and per-beneficiary spending, (2) unit cost increases over the preceding years, (3) initial launch price, and (4) any other criteria determined by CMS. CMS may negotiate lower prices
(continued...)
Spread the world
US Congress 114th Congress
A bill to provide emergency supplemental appropriations to address the Zika crisis. [S.2843]
[Healthcare ]
[Public Health ]
[International ]
[Medicare and Medicaid ]
[Funding ]
[Grants ]
[Pharmaceuticals ]
[Budget and Spending ]
[Disaster Relief ]
A bill to provide emergency supplemental appropriations to address the Zika crisis. This bill provides FY2016 emergency supplemental appropriations to the Departments of State and Health and Human Services (HHS) to prevent, prepare for, and respond to the Zika virus and other infectious diseases. The bill specifies permissible uses for the funds and designates the funds as an emergency requirement, which exempts the funds from discretionary spending limits. The bill provides appropriations to HHS for: the Centers for Disease Control and Prevention,
(continued...)
Spread the world
US Congress 114th Congress
A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists. [S.2772]
[Veterans ]
[Overdose Prevention ]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists. This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for: any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to reverse the effect of such an overdose, and education on their use.
Spread the world
US Congress 114th Congress
PROP Act of 2016 Promoting Responsible Opioid Prescribing Act of 2016 [S.2758]
[Healthcare ]
[Medicare and Medicaid ]
[Overdose Prevention ]
[Pharmaceuticals ]
[Public Health ]
[Social Security ]
PROP Act of 2016 Promoting Responsible Opioid Prescribing Act of 2016 This bill amends title XVIII (Medicare) of the Social Security Act to exclude certain pain-related measures for purposes of calculating incentive payments under the value-based purchasing program (VBP). (VBP is a program that links hospital payments to the quality of care provided.) Specifically, VPB measures shall not include measures based on a patient's assessment of: (1) the patient's need for pain medicine during a hospital stay; (2) how often, during the stay, the patient's
(continued...)
Spread the world
US Congress 114th Congress
Medicare Home Infusion Site of Care Act of 2015 [S.275]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Social Security ]
[Senior Citizens ]
Medicare Home Infusion Site of Care Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to authorize Medicare coverage of home infusion therapy and home infusion drugs. Directs the Secretary of Health and Human Services to implement the Medicare home infusion therapy benefit in a manner that ensures that: (1) Medicare beneficiaries have timely and appropriate access to infusion therapy in their homes, and (2) there is rapid and seamless coordination between drug coverage under Medicare part D (Voluntary Prescription Drug Benefit
(continued...)
Spread the world
US Congress 114th Congress
FDA and NIH Workforce Authorities Modernization Act [S.2700]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Science ]
[Labor, Jobs, Employment ]
FDA and NIH Workforce Authorities Modernization Act This bill amends the Public Health Service Act to revise the Silvio O. Conte Senior Biomedical Research Service to: (1) remove the limit on the number of members, (2) expand eligibility for appointment, (3) set a maximum pay rate, and (4) remove the option for members to contribute to the retirement system of an institution of higher education. The Government Accountability Office (GAO) must report on these amendments. This bill amends the Federal Food, Drug, and Cosmetic Act to grant the Food
(continued...)
Spread the world
US Congress 114th Congress
Mental Health Reform Act of 2016 [S.2680]
[Healthcare ]
[Mental Health ]
[Public Health ]
Mental Health Reform Act of 2016
Spread the world
US Congress 114th Congress
STOP Pain Act Safe Treatments and Opportunities to Prevent Pain Act [S.2678]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Science ]
[Mental Health ]
[Overdose Prevention ]
STOP Pain Act Safe Treatments and Opportunities to Prevent Pain Act This bill authorizes the National Institutes of Health (NIH) to intensify and coordinate NIH research into the understanding of pain, therapies for chronic pain, and alternatives to opioids (drugs with effects similar to opium) for pain treatments. The prioritization and direction of federally funded pain research must consider recommendations made by the Interagency Pain Research Coordinating Committee.
Spread the world
US Congress 114th Congress
National Biomedical Research Act [S.2624]
[Healthcare ]
[Science ]
[Public Health ]
National Biomedical Research Act
Spread the world
US Congress 114th Congress
Preventing Overprescribing for Pain Act of 2016 [S.2567]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
Preventing Overprescribing for Pain Act of 2016 This bill requires the Centers for Disease Control and Prevention to issue guidelines for the safe prescribing of opioids for the treatment of acute pain. (Opioids are drugs with effects similar to opium, such as certain pain medications.)